ReviewCancers2023

RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis.

Selvaraj Vimalraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.